Peter Doherty: What Is MHC Restriction? The 1996 Nobel Prize Explained
๐ Available in: English | ํ๊ตญ์ด
Peter Doherty and the Theory That Made It All Make Sense
⏱ In 30 Seconds
- ✓ Peter Doherty and Rolf Zinkernagel discovered that killer T cells recognise virus-infected cells only when viral antigens are presented together with the body’s own MHC molecules.
- ✓ This phenomenon, known as MHC restriction, explained why T cells respond to a precise combination of infection and self.
- ✓ The discovery built naturally on Frank Macfarlane Burnet’s clonal selection theory, which proposed that immune responses arise through the selection and expansion of specific lymphocyte clones.
- ✓ Doherty and Zinkernagel shared the 1996 Nobel Prize in Physiology or Medicine for revealing how the immune system recognises virus-infected cells.
For years, I knew clonal selection and MHC restriction as two fundamental concepts in immunology.
Like many things we learn in science, however, I tended to think of them separately.
It was only when I looked back at the history of these discoveries that I began to appreciate how beautifully the two ideas connect.
Burnet’s clonal selection theory helped explain how the immune system selects lymphocytes with the right specificity. But another fundamental question remained.
What exactly does a T cell recognise?
Almost two decades later, a puzzling experiment by Australian immunologist Peter Doherty and Swiss immunologist Rolf Zinkernagel provided an extraordinary answer.
A killer T cell does not simply recognise a virus.
It recognises viral antigen in the context of self.
That discovery eventually earned Doherty and Zinkernagel the 1996 Nobel Prize in Physiology or Medicine and became one of the foundational principles of modern cellular immunology.
A Puzzling Result in Mice
In the early 1970s, Doherty was working with Zinkernagel at the John Curtin School of Medical Research at the Australian National University in Canberra.
They were studying how mouse models respond to lymphocytic choriomeningitis virus, commonly abbreviated as LCMV.
Their experiment was conceptually simple.
They isolated cytotoxic T cells from virus-infected mice and tested whether those T cells could kill other infected cells in a laboratory dish.
The expectation was straightforward: if a target cell carried the virus, the virus-specific T cells should recognise and destroy it.
But that was not what happened.
The T cells killed infected target cells only when those targets came from a mouse with a matching genetic background.
More specifically, the target cells had to carry matching versions of proteins encoded by the major histocompatibility complex, or MHC.
Virus-infected cells from a genetically different mouse strain were left untouched, even though they carried the same virus.
The Immune System Was Checking Two Things at Once
The result revealed that a killer T cell was not simply asking:
“Is this cell infected?”
It was effectively asking two questions at the same time:
＋
Is it being displayed by the correct self-MHC molecule?
↓
If both conditions are satisfied, the T cell can attack.
Only target cells displaying the correct combination of viral antigen and self-MHC were destroyed.
Doherty and Zinkernagel published the finding in Nature in 1974.
The phenomenon became known as MHC restriction.
The discovery revealed that T cells do not recognise free-floating viral material in the same way that antibodies can recognise molecular shapes directly.
Instead, T-cell receptors examine fragments of proteins presented on the surface of cells by MHC molecules.
For cytotoxic CD8 T cells, viral peptides are generally presented by MHC class I molecules.
This arrangement allows T cells to inspect what is happening inside a cell without entering it.
A healthy cell displays one set of peptides. A virus-infected cell may display viral peptides among them.
The T cell recognises the combined molecular surface created by the peptide and the MHC molecule.
Why Clonal Selection Was the Key That Unlocked It
MHC restriction would have been much harder to interpret without a theoretical framework already in place.
That framework was clonal selection theory, developed approximately two decades earlier and most strongly associated with Australian immunologist Frank Macfarlane Burnet.
Burnet proposed that the body does not build a new immune receptor from scratch whenever a pathogen appears.
Instead, it generates a vast and diverse population of lymphocytes in advance.
Each lymphocyte carries a receptor with a particular specificity.
When an infection enters the body, the pathogen does not instruct the immune system how to construct the correct receptor.
It selects the lymphocyte clones whose receptors already recognise the relevant target.
Those selected cells then proliferate through clonal expansion, producing many cells with the same receptor specificity.
This theory explained how the immune system could prepare for an enormous range of possible infections without having encountered them previously.
It also implied that potentially self-reactive clones must be removed, inactivated or controlled to prevent damaging immune responses against the body.
From Clonal Selection to MHC Restriction
Doherty and Zinkernagel’s discovery added another level of precision to Burnet’s framework.
A T-cell clone was not selected merely because its receptor recognised something derived from a virus.
Its receptor had to recognise a very particular combined structure:
a specific foreign peptide presented by a particular self-MHC molecule.
This explained why the same virus could be recognised differently in animals with different MHC genes.
The T-cell receptor was responding not to viral antigen alone and not to self-MHC alone, but to the molecular combination formed by both.
The discovery also helped explain how T-cell specificity is established during immune development.
Developing T cells must acquire the ability to interact appropriately with the body’s own MHC molecules while avoiding strong destructive responses against self-components.
MHC restriction therefore became closely connected to the study of thymic selection, immune tolerance and the distinction between protective immunity and autoimmunity.
Two Ideas, Two Nobel Prizes, One Continuous Story
The intellectual connection between Burnet and Doherty is one of the most interesting chapters in Australian immunology.
The discoveries were made decades apart and at different Australian institutions. Burnet developed much of his immunological thinking at the Walter and Eliza Hall Institute of Medical Research in Melbourne, while Doherty and Zinkernagel performed their Nobel-recognised work at the John Curtin School of Medical Research in Canberra.
Burnet shared the 1960 Nobel Prize in Physiology or Medicine with Peter Medawar for discoveries concerning acquired immunological tolerance.
Doherty and Zinkernagel shared the 1996 Nobel Prize for discoveries concerning the specificity of cell-mediated immune defence.
Decades apart, the two discoveries helped establish how immune-cell specificity and recognition of self fit together.
Why This Discovery Still Matters
MHC restriction remains central to our understanding of infection, vaccination, transplantation, autoimmunity and cancer immunity.
T cells recognise viral or tumour-derived peptides presented by MHC molecules, while some modern therapies deliberately work around this system. Traditional CAR-T cells, for example, recognise molecules directly on the tumour-cell surface without requiring MHC presentation.
What I find most interesting is how this fundamental principle emerged from a puzzling experiment: virus-specific killer T cells ignored infected cells from the wrong mouse strain.
The immune system was not simply detecting infection. It was detecting infection in the context of self.
Looking back at the history also made the connection with Burnet’s clonal selection theory much clearer to me. I had learned clonal selection and MHC restriction as separate concepts, but the two discoveries are closely connected: one explains how specific lymphocyte clones are selected, while the other explains the context in which a T-cell clone recognises its target.
Continue Reading
- Jacques Miller and T Cells: The Discovery That Changed Immunology
- Macfarlane Burnet and the Clonal Selection Theory
- How Australian Scientists Discovered a New Immune Pathway in Rheumatic Heart Disease
- From Life-Saving Discovery to Drug Target: The Story of GM-CSF
This article is intended for general educational purposes. Readers seeking a more technical account should consult the original research, Nobel Prize materials and specialist immunology texts.